RxDoctor Payments Data

Felix Gonzales, MD

Otolaryngology · Fort Dodge, IANPI 1326006131

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,257 of the $1,888 with a category attached, or 66.6%. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 33.4% of the total. Reporting peaked in 2021 at $1,089 and has fallen 87.8% since, to $133 in 2022.

$1,888in general payments, 2019–2025

Across 49 payments — averaging $38.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$631
  • Acclarent, Inc$444
  • Intersect ENT, Inc.$308
  • Stryker$162
  • KARL Storz Endoscopy-america$91
  • Aerin Medical Inc.$66
  • plus $185 from 7 others

What the payments were for

  • Travel & lodging$63133%
  • Food & beverage$1,25767%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,888 in reported general payments places this provider in the 65th percentile of 103 otolaryngology providers in Iowa.

See all otolaryngology providers in Iowa

Medicare billing

Part B allowed, 2024
$139,756
Medicare patients
496
Services billed
906

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl164$4,092
Dexamethasone Sodium Phosphate61$2,219
Ofloxacin31$758
Flunisolide20$733
Tobramycin-DexamethasoneTobramycin/Dexamethasone15$718
Montelukast Sodium76$628
Prednisolone Sodium Phosphate18$602
Ipratropium Bromide20$443
Mupirocin43$410
Doxycycline Hyclate30$407
Fluticasone Propionate16$269
Cephalexin23$169
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$75
Prednisone19$71
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fort Dodge

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →